| Nome do produto |
betamethasone 21-phosphate sodium |
| Nome em inglês |
betamethasone 21-phosphate sodium; betamethasone 21-(disodium phosphate); BETA METHASONE SODIUM PHOSPHATE; 20-dione,9-fluoro-11-beta,17,21-trihydroxy-16-beta-methyl-pregna-4-diene-3; 21-(dihydrogenphosphate),disodiumsalt; bentelan; betamethasonedisodiumphosphate; BETMETHASONE DISODIUM PHOSPHATE; betnesol; BETAMETHASONE 21-DISODIUM PHOSPHATE; betamethasone 21-phosphate disodium; BETAMETHASONE 21-PHOSPHATE SODIUM SALT; BETAMETHASONE SODIUM PHOSPHATE; 9a-fluoro-16b-methylprednisolone-21-(disodium phosphate); 1,4-PREGNADIEN-9-ALPHA-FLUORO-16-BETA-METHYL-11-BETA, 17,21-TRIOL-3,20-DIONE 21-PHOSPHATE, DISODIUM SALT; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, disodium salt, (11beta,16beta)-; Pregna-1,4-Diene-3,20-Dione,9-Fluoro-11,17-Dihydroxy-16-Methyl-21-(Phosphonooxy)-,DisodiumSalt,(11Beta,16Beta)-; BETAMETHASONE 21-PHOSPHATE DISODIUM SALT; Celestan; Disodium betamethasone 21-phosphate; Durabetason; NSC 90616; Pregna-1,4-diene-3,20-dione, 9-fluoro-11β,17,21-trihydroxy-16β-methyl-, 21-(dihydrogen phosphate), disodium salt (7CI, 8CI); Vista-Methasone; disodium (11beta,16beta)-9-fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl phosphate |
| Fórmula molecular |
C22H28FNa2O8P |
| Peso Molecular |
516.4046 |
| InChI |
InChI=1/C22H30FO8P.2Na/c1-12-8-16-15-5-4-13-9-14(24)6-7-19(13,2)21(15,23)17(25)10-20(16,3)22(12,27)18(26)11-31-32(28,29)30;;/h6-7,9,12,15-17,25,27H,4-5,8,10-11H2,1-3H3,(H2,28,29,30);;/q;2*+1/p-2/t12-,15-,16-,17-,19-,20-,21-,22-;;/m0../s1 |
| CAS Registry Number |
151-73-5 |
| EINECS |
205-797-0 |
| Estrutura Molecular |
|
| Ponto de ebulição |
669.6°C at 760 mmHg |
| O ponto de inflamação |
358.7°C |
| Pressão de vapor |
8.62E-21mmHg at 25°C |
| Símbolos de perigo |
 Xn:Harmful;
|
| Códigos de risco |
R22:;
|
| Descrição da Segurança |
S36:;
|
|
